NR2C2 and renal cell carcinoma: Inhibition of TR4 with small molecule compounds, such as tretinoin, blocks lncTASR gene transcription, leading to sensitivity of RCC cells to sunitinib therapy in vitro and suppression of RCC tumor progression in mouse models [67].